1
|
Pisaltu S, Ruotolo I, Sellitto G, Berardi A, Simeon R, Fabbrini G, Galeoto G. Validity and reliability of the Italian version of the short Parkinson's evaluation scale (SPES/SCOPA). Heliyon 2024; 10:e32877. [PMID: 39021984 PMCID: PMC11253227 DOI: 10.1016/j.heliyon.2024.e32877] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2024] [Revised: 06/10/2024] [Accepted: 06/11/2024] [Indexed: 07/20/2024] Open
Abstract
Background In the medical and rehabilitative field, it is essential to employ tools such as evaluation scales and performance tests to assess the impact of Parkinson's disease on QoL of affected individuals. The Short Parkinson's Evaluation Scale (SPES) is a reliable and valid tool, applicable both in research and clinical practices, useful in assessing motor damage, activities of daily living, and motor complications in patients with Parkinson's disease. The aim of the study is to investigate validity and reliability of the Italian version of the SPES-SCOPA scale. Methods Translation and cultural adaptation were performed. Included patients had diagnosis of Parkinson's disease, no concurrent pathologies, MiniMental test score above 2 and signed informed consent; they were recruited at the Department of Human Neurosciences in Sapienza University of Rome, from February 2023 to November 2023. Test-retest reliability was evaluated through Intraclass Correlation Coefficient (ICC), internal consistency was assessed using Cronbach's Alpha and construct validity using Pearson's correlation between SPES-SCOPA and the gold standard PDQ-39. Results 101 patients were recruited. Inter-rater evaluation was conducted on 62 patients, while 39 underwent an intra-rater assessment. The analysis showed statistically significant data with a Cronbach's Alpha value of 0.89 for the entire scale; test-retest reliability results are statistically significant for all subscales. Correlation between PDQ-39 domains and SPES/SCOPA subscales were statistically significant for most measurements. Conclusion This research shows that the Italian version of SPES-SCOPA scale has excellent psychometric properties.
Collapse
Affiliation(s)
| | - I. Ruotolo
- Sapienza University of Rome, Department of Human Neuroscience, 00185, Rome, Italy
| | - G. Sellitto
- Sapienza University of Rome, Department of Human Neuroscience, 00185, Rome, Italy
| | - A. Berardi
- Sapienza University of Rome, Department of Human Neuroscience, 00185, Rome, Italy
| | - R. Simeon
- Sapienza University of Rome, Department of Human Neuroscience, 00185, Rome, Italy
| | - G. Fabbrini
- Sapienza University of Rome, Department of Human Neuroscience, 00185, Rome, Italy
- IRCCS Neuromed, Via Atinense, 18, 86077, Pozzilli, IS, Italy
| | - G. Galeoto
- Sapienza University of Rome, Department of Human Neuroscience, 00185, Rome, Italy
- IRCCS Neuromed, Via Atinense, 18, 86077, Pozzilli, IS, Italy
| |
Collapse
|
2
|
Ruotolo I, Sellitto G, Berardi A, Simeon R, Panuccio F, Amadio E, Ugolini A, Fabbrini G, Galeoto G. Psychometric properties of the Parkinson's disease Questionnaire-39 and its short form Parkinson's disease Questionnaire-8: A systematic review and meta-analysis. J Clin Neurosci 2024; 123:100-117. [PMID: 38564966 DOI: 10.1016/j.jocn.2024.03.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2024] [Revised: 03/23/2024] [Accepted: 03/28/2024] [Indexed: 04/04/2024]
Abstract
Parkinson's disease (PD) affects Quality of Life (QoL), since it is responsible for cognitive impairment, non-motor, and motor symptoms. Outcome measures are fundamental for evaluating treatment's effect on QoL over time. This systematic review aimed to identify the psychometric properties of PDQ-39 and PDQ-8 in the different populations in which they were validated. The electronic databases systematically searched are MEDLINE (via PubMed), CINAHL, SCOPUS, and Web of Science; the research was conducted in July 2023. The psychometric properties considered were those of the COnsensus-based Standards for the selection of health Measurement Instruments (COSMIN) checklist. Risk of bias was assessed using the COSMIN checklist. The search identified 1306 articles. 398 duplicates were eliminated; 908 articles were analyzed reading title and abstract; 799 were finally excluded because used PDQ-39 and PDQ-8 as outcome measures or were not dealing with psychometric properties; 66 articles were excluded after reading the full text. 43 articles were included in the review; meta-analysis showed all the Cronbach's alpha values were statistically significant for all the subscales of PDQ-39 and PDQ-8. PDQ-39 demonstrated to be a specific HRQoL questionnaire that is correlated with generic HRQoL questionnaires, in fact in many studies included in the review, correlations with SF-36 were found. In the last studies about psychometric properties of PDQ-8 emerged that it is a practical and informative instrument that can be easily used in clinical settings, especially in busy ones, but also in large-scale studies in which a brief instrument would be preferred.
Collapse
Affiliation(s)
- Ilaria Ruotolo
- Department of Human Neurosciences, Sapienza University of Rome, Italy.
| | - Giovanni Sellitto
- Department of Human Neurosciences, Sapienza University of Rome, Italy
| | - Anna Berardi
- Department of Human Neurosciences, Sapienza University of Rome, Italy
| | | | | | | | | | - Giovanni Fabbrini
- Department of Human Neurosciences, Sapienza University of Rome, Italy; IRCCS Neuromed, Via Atinense, 18, 86077 Pozzilli, IS, Italy
| | - Giovanni Galeoto
- Department of Human Neurosciences, Sapienza University of Rome, Italy; IRCCS Neuromed, Via Atinense, 18, 86077 Pozzilli, IS, Italy
| |
Collapse
|
3
|
Sellitto G, Ruotolo I, Ianniello A, Felicetti F, D'Ambrosi G, Berardi A, Galeoto G, Conte A, Pozzilli C. Clinical variables influencing the perception of fatigue in people with multiple sclerosis: a cross-sectional study using FSIQ-RMS. BMC Neurol 2024; 24:138. [PMID: 38664640 PMCID: PMC11044535 DOI: 10.1186/s12883-024-03643-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2023] [Accepted: 04/17/2024] [Indexed: 04/29/2024] Open
Abstract
BACKGROUND Physical fatigue is one of the most disabling symptoms in people with Multiple Sclerosis (PwMS). Several factors might influence the development of fatigue, such as gender, education, body mass index (BMI), Expanded Disability Status Scale (EDSS), disease duration, working status (Ws), physiotherapy (Ph), and disease-modifying therapies (DMTs). Fatigue Symptoms and Impacts Questionnaire-Relapsing Multiple Sclerosis (FSIQ-RMS) is a patient-reported outcome (PRO) that allows one to define the impact of fatigue in PwMS clearly. This study aimed to assess fatigue impact on PwMS by using FSIQ-RMS. METHODS The participants were enrolled from May to July 2021 in MS Centers of Sant'Andrea Hospital and Policlinico Umberto I Hospital in Rome. Fatigue was evaluated using the FSIQ-RMS, validated, and culturally adapted in Italian. Clinical and demographic data were collected at the same time. RESULTS We enrolled 178 PwMS [Female 74.16%; RMS 82.58%, SPMS 17.52%]. FSIQ-RMS scores were significantly correlated with EDSS (p-value < 0.01). Analysis of variance between means showed a statistically significant difference between the BMI groups at the 24hours_FSIQ-RMS score and the 7days_FSIQ-RMS score (p < 0.01), with the lower BMI group having the highest scores. Furthermore, perceived fatigue significantly improved both in subjects performing Ph (p < 0.05) and in those who actively work (p < 0.01). CONCLUSIONS The use of FSIQ-RMS in a real-world setting confirmed that underweight and high levels of disability are closely related to fatigue. In addition, Ph and active Ws are strongly correlated with fatigue in PwMS.
Collapse
Affiliation(s)
- Giovanni Sellitto
- MS Center, S. Andrea Hospital, Sapienza University, Rome, Italy.
- Department of Human Neurosciences, Sapienza University, Rome, Italy.
| | - Ilaria Ruotolo
- MS Center, S. Andrea Hospital, Sapienza University, Rome, Italy
- Department of Human Neurosciences, Sapienza University, Rome, Italy
| | | | | | | | - Anna Berardi
- Department of Human Neurosciences, Sapienza University, Rome, Italy
| | - Giovanni Galeoto
- IRCCS Neuromed, Pozzilli, Italy
- Department of Human Neurosciences, Sapienza University, Rome, Italy
| | - Antonella Conte
- IRCCS Neuromed, Pozzilli, Italy
- Department of Human Neurosciences, Sapienza University, Rome, Italy
| | - Carlo Pozzilli
- MS Center, S. Andrea Hospital, Sapienza University, Rome, Italy
- Department of Human Neurosciences, Sapienza University, Rome, Italy
| |
Collapse
|
4
|
Berardi A, Graziosi G, Ferrazzano G, Casagrande Conti L, Grasso MG, Tramontano M, Conte A, Galeoto G. Evaluation of the Psychometric Properties of the Revised Piper Fatigue Scale in Patients with Multiple Sclerosis. Healthcare (Basel) 2022; 10:healthcare10060985. [PMID: 35742037 PMCID: PMC9222278 DOI: 10.3390/healthcare10060985] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2022] [Revised: 05/11/2022] [Accepted: 05/23/2022] [Indexed: 02/01/2023] Open
Abstract
Background: Fatigue is one of the most common symptoms in patients with multiple sclerosis (MS), and has a major impact on their quality of life. Measurement tools that assess the patient’s condition are commonly used in the neurological field, though diagnostic tools are currently unable to distinguish potential alternative causes of fatigue in individual patients. The Revised Piper Fatigue Scale (PFS-R) is a self-administered assessment scale that is internationally used for fatigue measurement. Aim: This study aimed to evaluate the reliability and validity of the Italian version of the PFS-R in patients with MS. Methods: Forty-one individuals were included in this study. Each participant in the study was given a dossier, in paper format, containing the informed consent form, a personal data sheet, the Fatigue Symptoms and Impacts Questionnaire in Relapsing Multiple Sclerosis (FSIQ-RMS), the Fatigue Severity Scale (FSS), and the PFS-R. Results: The PFS-R was found to have strong internal consistency, with a value of α equal to 0.977. Correlations between PFS-R, FSS, and FSIQ-RMS scores were analyzed using the Pearson correlation coefficient, and all scales showed statistically significant correlations. Conclusion: The PFS-R is a new self-administered tool to assess fatigue in patients with MS. It evaluates fatigue characteristics, difficulty in carrying out daily life activities, and how the individual feels as a result of this symptom. This tool was previously validated for use in cancer patients, which also allows us to make a comparison between different pathologies and rehabilitation treatments.
Collapse
Affiliation(s)
- Anna Berardi
- Department of Human Neurosciences, Sapienza University of Rome, 001859 Rome, Italy; (G.F.); (A.C.)
- Correspondence: (A.B.); (G.G.)
| | - Giulia Graziosi
- School of Occupational Therapy, Sapienza University of Rome, 00185 Rome, Italy;
| | - Gina Ferrazzano
- Department of Human Neurosciences, Sapienza University of Rome, 001859 Rome, Italy; (G.F.); (A.C.)
| | - Laura Casagrande Conti
- Santa Lucia Foundation IRCCS, Via Ardeatina, 306, 00179 Rome, Italy; (L.C.C.); (M.G.G.); (M.T.)
| | - Maria Grazia Grasso
- Santa Lucia Foundation IRCCS, Via Ardeatina, 306, 00179 Rome, Italy; (L.C.C.); (M.G.G.); (M.T.)
| | - Marco Tramontano
- Santa Lucia Foundation IRCCS, Via Ardeatina, 306, 00179 Rome, Italy; (L.C.C.); (M.G.G.); (M.T.)
| | - Antonella Conte
- Department of Human Neurosciences, Sapienza University of Rome, 001859 Rome, Italy; (G.F.); (A.C.)
- IRCCS Neuromed, 86077 Pozzilli, Italy
| | - Giovanni Galeoto
- Department of Human Neurosciences, Sapienza University of Rome, 001859 Rome, Italy; (G.F.); (A.C.)
- IRCCS Neuromed, 86077 Pozzilli, Italy
- Correspondence: (A.B.); (G.G.)
| |
Collapse
|